How Schrödinger Cut its NDA Processing Time by 93%
A cutting-edge computational platform that accelerates drug discovery chose Marshfield Consulting to create a scalable NDA process from generation through signature, all built on DocuSign CLM technology.
Schrödinger’s Legal team handled up to 5 new NDAs a day through a patchwork of disconnected forms, spreadsheets, manually edited templates, and emails. The process demanded 10+ hours per week and lacked collaborative redlining. Without a unified system, sales reps and customers lacked visibility into an NDA’s status.
After selecting DocuSign CLM, Schrödinger opted for Marshfield based on the consultancy’s knowledge of workflows and flexibility in building solutions—and glowing recommendation from DocuSign CLM’s account executive.
The new process merges the requestor’s information into an NDA template, checks for duplicates, and routes for approval and signature. Rejections are automatically queued for collaborative redlining, with full version control and multiple options for re-routing based on the suggested changes. Sales and customers receive notifications at every step.
Signed NDAs are stored in DocuSign CLM, serving as one central repository with advanced search and reporting functionality. To help ensure compliance with NDA terms, the system sends automated alerts when NDAs are 30 days from their expiration date.
Benefits & Results
Processing time for an average NDA has dropped from 30 minutes to 2—a 93% reduction in time. Complex NDAs that once demanded 45-60 minutes of manual intervention now take 10 minutes of Legal’s time.
The signature step’s automated notifications spare the Legal team from chasing signatures, one of the most time-consuming aspects of the old system. Because everything lives in DocuSign CLM, tracking progress and reviewing version history takes place in the same location.
The Legal administrative team can now focus on board meetings and committees, actions of written consent, and corporate record-keeping.
Based on the new NDA process’s unqualified success, Schrodinger plans to partner with Marshfield again to create NDA amendments and software-licensing contracts within DocuSign CLM.
“Marshfield’s always there helping. Any time I ask, ‘How can I do this?’ or ‘What’s the best way to accomplish this?’ they have the answer.”
“In the same amount of time that it would have taken me to read the email request and start the old process, an NDA can already be on its way to the external party.”
Paralegal & Legal Administrator, Schrödinger
Average NDA processing time cut by
Complex NDA processing time cut by
Schrödinger’s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading pharmaceutical, biotechnology, chemical, and electronics companies worldwide. In addition to this substantial and growing global business, Schrödinger has built a robust pipeline of therapeutic assets, held both internally and in partnerships, and has co-founded leading biotech companies including Nimbus Therapeutics and Morphic Therapeutic. Schrödinger’s significant and ongoing investment in basic research continues to drive advances in its computational platform. Founded in 1990, Schrödinger has nearly 400 employees in its New York City headquarters and around the world.